Magnetic Resonance Imaging of the Liver in Children 0-2 Months of Age With an Intravenous Injection of Eovist/Primovist Which is a Contrast Agent
Clinical trial NCT02084628 · TERMINATED
Trial details
- NCT number
- NCT02084628
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2015-08-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.